|
|
||||||||
Division of Cell Biology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
One of the major proteins that is rapidly tyrosine phosphorylated
upon stimulation of the TCR/CD3 complex is the 120-kDa product of the
c-cbl protooncogene (Cbl). Upon activation,
tyrosine-phosphorylated Cbl interacts with the Src homology 2 (SH2)
domains of several signaling proteins, e.g., phosphatidylinositol
3-kinase (PI3-K) and CrkL. In the present study, we report that
pretreatment of Jurkat T cells with PMA reduced the
anti-CD3-induced tyrosine phosphorylation of Cbl and, consequently,
its activation-dependent association with PI3-K and CrkL. A specific
protein kinase C (PKC) inhibitor (GF-109203X) reversed the effect of
PMA on tyrosine phosphorylation of Cbl and restored the
activation-dependent association of Cbl with PI3-K and CrkL. We also
provide evidence that PKC
and PKC
can physically associate with
Cbl and are able to phosphorylate it in vitro and in vivo. Furthermore,
a serine-rich motif at the C terminus of Cbl, which is critical for
PMA-induced 14-3-3 binding, is also phosphorylated by PKC
and PKC
in vitro. These results suggest that, by regulating tyrosine and serine
phosphorylation of Cbl, PKC is able to control the association of Cbl
with signaling intermediates, such as SH2 domain-containing proteins
and 14-3-3 proteins, which may consequently result in the modulation of
its function.
This article has been cited by other articles:
![]() |
I. Foucault, Y.-C. Liu, A. Bernard, and M. Deckert The Chaperone Protein 14-3-3 Interacts with 3BP2/SH3BP2 and Regulates Its Adapter Function J. Biol. Chem., February 21, 2003; 278(9): 7146 - 7153. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tzivion and J. Avruch 14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation J. Biol. Chem., January 25, 2002; 277(5): 3061 - 3064. [Full Text] [PDF] |
||||
![]() |
X. Lin, A. O'Mahony, Y. Mu, R. Geleziunas, and W. C. Greene Protein Kinase C-theta Participates in NF-kappa B Activation Induced by CD3-CD28 Costimulation through Selective Activation of Ikappa B Kinase beta Mol. Cell. Biol., April 15, 2000; 20(8): 2933 - 2940. [Abstract] [Full Text] |
||||
![]() |
E. Rollet-Labelle, C. Gilbert, and P. H. Naccache Modulation of Human Neutrophil Responses to CD32 Cross-Linking by Serine/Threonine Phosphatase Inhibitors: Cross-Talk Between Serine/Threonine and Tyrosine Phosphorylation J. Immunol., January 15, 2000; 164(2): 1020 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Uemura and J. D. Griffin The Adapter Protein Crkl Links Cbl to C3G after Integrin Ligation and Enhances Cell Migration J. Biol. Chem., December 31, 1999; 274(53): 37525 - 37532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Villalba, S. Kasibhatla, L. Genestier, A. Mahboubi, D. R. Green, and A. Altman Protein Kinase C{theta} Cooperates with Calcineurin to Induce Fas Ligand Expression During Activation-Induced T Cell Death J. Immunol., December 1, 1999; 163(11): 5813 - 5819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Varadhachary, M. E. Peter, S. N. Perdow, P. H. Krammer, and P. Salgame Selective Up-Regulation of Phosphatidylinositol 3'-Kinase Activity in Th2 Cells Inhibits Caspase-8 Cleavage at the Death-Inducing Complex: A Mechanism for Th2 Resistance from Fas-Mediated Apoptosis J. Immunol., November 1, 1999; 163(9): 4772 - 4779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bao, I. Alroy, H. Waterman, E. D. Schejter, C. Brodie, J. Gruenberg, and Y. Yarden Threonine Phosphorylation Diverts Internalized Epidermal Growth Factor Receptors from a Degradative Pathway to the Recycling Endosome J. Biol. Chem., August 18, 2000; 275(34): 26178 - 26186. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pedraza-Alva, S. Sawasdikosol, Y. C. Liu, L. B. Merida, M. E. Cruz-Munoz, F. Oceguera-Yanez, S. J. Burakoff, and Y. Rosenstein Regulation of Cbl Molecular Interactions by the Co-receptor Molecule CD43 in Human T Cells J. Biol. Chem., January 5, 2001; 276(1): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |